Insider Transactions in Q3 2025 at Gemini Therapeutics, Inc. (GMTX)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 24
2025
|
Kevin Bitterman |
SELL
Open market or private sale
|
Indirect |
13,033
-2.01%
|
$795,013
$61.17 P/Share
|
|
Jul 23
2025
|
Kevin Bitterman |
SELL
Open market or private sale
|
Indirect |
29,837
-4.41%
|
$1,790,220
$60.97 P/Share
|
|
Jul 18
2025
|
Kevin Bitterman |
SELL
Open market or private sale
|
Indirect |
664
-0.1%
|
$40,504
$61.13 P/Share
|
|
Jul 17
2025
|
Jean M. Franchi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,031
-3.1%
|
$119,829
$59.0 P/Share
|
|
Jul 10
2025
|
Jean M. Franchi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,000
-2.96%
|
$114,000
$57.5 P/Share
|
|
Jul 09
2025
|
John D Quisel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
34,800
-9.02%
|
$1,914,000
$55.72 P/Share
|
|
Jul 09
2025
|
John D Quisel Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
34,800
+15.04%
|
$313,200
$9.86 P/Share
|
|
Jul 03
2025
|
John D Quisel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,200
-3.11%
|
$286,000
$55.09 P/Share
|
|
Jul 03
2025
|
John D Quisel Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,200
+3.02%
|
$46,800
$9.86 P/Share
|